Jesse T. Chao

Jesse T. Chao

Auto-generated profile, based on publicly available information

Jesse T. Chao

Department of Medical Biophysics, Sunnybrook Research Institute, The University of Toronto, 2075 Bayview Avenue, E240, Toronto, Ontario, Canada, M4N 3M5

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2014 in PLOS Biology
Verified
Journal Article
Open access
PDF file
SLSujoy Lahiri
Sujoy Lahiri
JCJesse T. Chao
Jesse T. Chao
STShabnam Tavassoli
Shabnam Tavassoli
AWAndrew K. O. Wong
Andrew K. O. Wong
VCVineet Choudhary
Vineet Choudhary
WPWilliam A. Prinz
William A. Prinz
Mitochondrial membrane biogenesis and lipid metabolism require phospholipid transfer from the endoplasmic reticulum (ER) to mitochondria. Transfer is thought to occur at regions of close contact of these organelles and to be nonvesicular, but the mechanism is not known. Here we used a novel genetic screen in S. cerevisiae to identify mutants with defects in lipid exchange between the ER and mitochondria. We show that a strain missing multiple components of the conserved ER membrane protein complex (EMC) has decreased phosphatidylserine (PS) transfer from the ER to mitochondria. Mitochondria from this strain have significantly reduced levels of PS and its derivative phosphatidylethanolamine (PE). Cells lacking EMC proteins and the ER–mitochondria tethering complex called ERMES (the ER–mitochondria encounter structure) are inviable, suggesting that the EMC also functions as a tether. These defects are corrected by expression of an engineered ER–mitochondrial tethering protein that artificially tethers the ER to mitochondria. EMC mutants have a significant reduction in the amount of ER tethered to mitochondria even though ERMES remained intact in these mutants, suggesting that the EMC performs an additional tethering function to ERMES. We find that all Emc proteins interact with the mitochondrial translocase of the outer membrane (TOM) complex protein Tom5 and this interaction is important for PS transfer and cell growth, suggesting that the EMC forms a tether by associating with the TOM complex. Together, our findings support that the EMC tethers ER to mitochondria, which is required for phospholipid synthesis and cell growth. Mitochondrial membrane biogenesis and lipid metabolism depend on the transfer of phospholipid from the endoplasmic reticulum to mitochondria. This transfer is thought to occur at regions where these organelles are in close contact, and, although the process is thought not to involve vesicles, the mechanism is not known. In this study, we found a complex of proteins in the endoplasmic reticulum that is required for the transfer of one phospholipid—phosphatidylserine—from the endoplasmic reticulum to mitochondria. Cells lacking this protein complex have nonfunctional mitochondria with an abnormal lipid composition. We show that the complex is required to maintain close contacts between the endoplasmic reticulum and mitochondria; the complex probably directly interacts with at least one protein on the surface of mitochondria. In addition, cells lacking this complex and a second previously identified tethering complex are not viable. Thus, our findings suggest that tethering of the endoplasmic reticulum and mitochondria is essential for cell growth, likely because it is necessary for lipid exchange between these organelles.

27 August 2010 in Science
Verified
Journal Article
Closed access
PDF file
BYBarry P. Young
Barry P. Young
JSJohn J. H. Shin
John J. H. Shin
RORick Orij
Rick Orij
JCJesse T. Chao
Jesse T. Chao
SLShu Chen Li
Shu Chen Li
CLChristopher J. R. Loewen
Christopher J. R. Loewen
Intracellular pH and Lipid Metabolism: Intracellular pH regulates metabolism by poorly understood mechanisms, but biosensors are likely to be important in this process. Young et al. (p. 1085 ) took a systems-biology approach in yeast to identify in excess of 200 genes that regulate phospholipid metabolism. They found that the signaling lipid, phosphatidic acid, appeared to act as a cytosolic biosensor via the pH-dependent binding of protein effectors to phosphatidic acid. This pH-dependent mechanism directly affects gene expression and is involved in a pathway in which nutrient availability regulates phospholipid metabolism to control production of membranes.

22 March 2013 in EMBO Reports
Verified
Journal Article
Open access
PDF file
STShabnam Tavassoli
Shabnam Tavassoli
JCJesse T Chao
Jesse T Chao
BYBarry P Young
Barry P Young
RCRuud C Cox
Ruud C Cox
WPWilliam A Prinz
William A Prinz
CLChristopher J R Loewen
Christopher J R Loewen
Synthesis of phospholipids, sterols and sphingolipids is thought to occur at contact sites between the endoplasmic reticulum (ER) and other organelles because many lipid‐synthesizing enzymes are enriched in these contacts. In only a few cases have the enzymes been localized to contacts in vivo and in no instances have the contacts been demonstrated to be required for enzyme function. Here, we show that plasma membrane (PM)—ER contact sites in yeast are required for phosphatidylcholine synthesis and regulate the activity of the phosphatidylethanolamine N ‐methyltransferase enzyme, Opi3. Opi3 activity requires Osh3, which localizes to PM–ER contacts where it might facilitate in trans catalysis by Opi3. Thus, membrane contact sites provide a structural mechanism to regulate lipid synthesis. There is a [Hot off the Press][1] (May 2013) associated with this Scientific Report. [1]: http://dx.doi.org/10.1038/embor.2013.43

1 July 2014 in Cell
Verified
Journal Article
Closed access
JCJesse T. Chao
Jesse T. Chao
AWAndrew K.O. Wong
Andrew K.O. Wong
STShabnam Tavassoli
Shabnam Tavassoli
BYBarry P. Young
Barry P. Young
ACAdam Chruscicki
Adam Chruscicki
CLChristopher J.R. Loewen
Christopher J.R. Loewen

1 October 2019 in Developmental Cell
Verified
Journal Article
Closed access
JCJesse T. Chao
Jesse T. Chao
FPFrancisco Piña
Francisco Piña
MOMasayuki Onishi
Masayuki Onishi
YCYifat Cohen
Yifat Cohen
YLYa-Shiuan Lai
Ya-Shiuan Lai
MNMaho Niwa
Maho Niwa

1 July 2020 in Cancer Research
Verified
Journal Article
Open access
PDF file
JCJesse T. Chao
Jesse T. Chao
RHRocio Hollman
Rocio Hollman
WMWarren M. Meyers
Warren M. Meyers
FMFabian Meili
Fabian Meili
KMKenneth Matreyek
Kenneth Matreyek
CLChristopher J.R. Loewen
Christopher J.R. Loewen
As sequencing becomes more economical, we are identifying sequence variations in the population faster than ever. For disease-associated genes, it is imperative that we differentiate a sequence variant as either benign or pathogenic, such that the appropriate therapeutic interventions or surveillance can be implemented. PTEN is a frequently mutated tumor suppressor that has been linked to the PTEN hamartoma tumor syndrome. Although the domain structure of PTEN and the functional impact of a number of its most common tumor-linked mutations have been characterized, there is a lack of information about many recently identified clinical variants. To address this challenge, we developed a cell-based assay that utilizes a premalignant phenotype of normal mammary epithelial cells lacking PTEN. We measured the ability of PTEN variants to rescue the spheroid formation phenotype of PTEN−/− MCF10A cells maintained in suspension. As proof of concept, we functionalized 47 missense variants using this assay, only 19 of which have clear classifications in ClinVar. We utilized a machine learning model trained with annotated genotypic data to classify variants as benign or pathogenic based on our functional scores. Our model predicted with high accuracy that loss of PTEN function was indicative of pathogenicity. We also determined that the pathogenicity of certain variants may have arisen from reduced stability of the protein product. Overall, this assay outperformed computational predictions, was scalable, and had a short run time, serving as an ideal alternative for annotating the clinical significance of cancer-associated PTEN variants. Significance: Combined three-dimensional tumor spheroid modeling and machine learning classifies PTEN missense variants, over 70% of which are currently listed as variants of uncertain significance.